Morepen Laboratories reports gross revenue of Rs 427cr in Q4 FY 2023-24
Morepen Laboratories Limited (NSE: MOREPENLAB, BSE: 500288), a prominent figure in the Medical Devices and Active Pharmaceutical Ingredients (API) sectors, has announced stellar financial results for the fiscal year 2023-24, marking its 40th year of operations. Demonstrating significant growth across its business segments, Morepen has emerged stronger in both the domestic and international markets. Morepen […]